A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants

Summary

The purpose of this study is to assess whether taking lasmiditan and sumatriptan together will have any additional effects on heart rate and blood pressure compared to taking lasmiditan and sumatriptan individually. This study will also look at the amount of study drug that gets into the blood stream and how long it takes the body to get rid of it when these two drugs are taken together. This study will last about 21 days, not including the screening. Participants will spend 16 days/15 nights in the clinical research unit (CRU) followed by follow-up. Screening is required within 28 days prior to the start of the study.

Timeline

Start

2017-10-17

Primary completion

2017-12-23

Completion

2017-12-23

Drugs

Indications

No indication recorded.